Since these authors did not investigate if lovastatin directly inhibited DNMT enzyme activity, it cannot be ruled out that the observed decrease in activity is a result of changed phenotype, as they did observe increased differentiation and reduced ‘stemness’ of the cancer cells. This evidence concerns the gene DNMT1 and cancer.